BioCryst Pharmaceuticals ... (BCRX)
NASDAQ: BCRX
· Real-Time Price · USD
7.58
-0.07 (-0.92%)
At close: Sep 26, 2025, 1:13 PM
BioCryst Pharmaceuticals Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for BCRX stock have an median target of 16, with a low estimate of 11 and a high estimate of 20. The median target predicts an increase of 111.08% from the current stock price of 7.58.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 11 | 15.5 | 16 | 20 |
| Change | 45.12% | 104.49% | 111.08% | 163.85% |
Latest Analyst Insight Report
Needham has reaffirmed its Buy rating for BioCryst... Unlock content with Pro Subscription
Updated Aug 04, 2025
| Rating | Mar 25 | Apr 25 | May 25 | Jun 25 | Jul 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 0 | 1 | 0 |
| Buy | 1 | 3 | 3 | 4 | 0 | 1 |
| Hold | 0 | 0 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 3 | 5 | 4 | 1 | 1 |
Financial Forecast this Year
Revenue This Year
626.42M
from 450.71M
Increased by 39.0%
Revenue Next Year
662.65M
from 626.42M
Increased by 5.8%
EPS This Year
0.1
from -0.43
Increased by 76.7%
EPS Next Year
0.54
from 0.1
Increased by 440.0%